Total Payments
$37,741
2024 Payments
$27.84
Companies
5
Transactions
60
Medicare Patients
4,417
Medicare Billing
$697,232
Payment Breakdown by Category
Other$31,780 (84.2%)
Travel$4,699 (12.5%)
Food & Beverage$1,217 (3.2%)
Consulting$45.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,025 | 10 | 45.1% |
| Honoraria | $14,755 | 15 | 39.1% |
| Travel and Lodging | $4,699 | 7 | 12.5% |
| Food and Beverage | $1,217 | 27 | 3.2% |
| Consulting Fee | $45.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $37,609 | 53 | $0 (2022) |
| MERZ NORTH AMERICA, INC. | $66.22 | 4 | $0 (2017) |
| Amgen Inc. | $27.84 | 1 | $0 (2024) |
| Mallinckrodt LLC | $23.18 | 1 | $0 (2017) |
| ABBVIE INC. | $14.76 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.84 | 1 | Amgen Inc. ($27.84) |
| 2022 | $15,434 | 20 | Horizon Therapeutics plc ($15,420) |
| 2021 | $11,996 | 19 | Horizon Therapeutics plc ($11,996) |
| 2020 | $10,180 | 14 | Horizon Therapeutics plc ($10,180) |
| 2019 | $13.74 | 1 | Horizon Therapeutics plc ($13.74) |
| 2017 | $89.40 | 5 | MERZ NORTH AMERICA, INC. ($66.22) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/16/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: TEPEZZA | ||||||
| 11/16/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $525.00 | General |
| Category: TEPEZZA | ||||||
| 11/01/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $1,305.00 | General |
| Category: TEPEZZA | ||||||
| 10/19/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: TEPEZZA | ||||||
| 10/18/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | In-kind items and services | $1,389.89 | General |
| Category: TEPEZZA | ||||||
| 10/18/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $122.96 | General |
| Category: TEPEZZA | ||||||
| 10/18/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | In-kind items and services | $65.00 | General |
| Category: TEPEZZA | ||||||
| 09/21/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $104.32 | General |
| Category: TEPEZZA | ||||||
| 08/19/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: TEPEZZA | ||||||
| 06/30/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/16/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: TEPEZZA | ||||||
| 05/04/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: TEPEZZA | ||||||
| 04/12/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: TEPEZZA | ||||||
| 03/22/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: TEPEZZA | ||||||
| 03/15/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $111.35 | General |
| Category: TEPEZZA | ||||||
| 03/09/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | In-kind items and services | $1,263.82 | General |
| Category: TEPEZZA | ||||||
| 03/09/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Travel and Lodging | In-kind items and services | $182.00 | General |
| Category: TEPEZZA | ||||||
| 03/09/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $110.73 | General |
| Category: TEPEZZA | ||||||
| 02/08/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: TEPEZZA | ||||||
| 02/01/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: TEPEZZA | ||||||
| 11/02/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: TEPEZZA | ||||||
| 10/19/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: TEPEZZA | ||||||
| 10/19/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: TEPEZZA | ||||||
| 09/29/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,215 | 6,258 | $612,163 | $194,045 |
| 2022 | 19 | 1,075 | 5,390 | $516,317 | $167,855 |
| 2021 | 20 | 1,145 | 5,481 | $548,049 | $184,517 |
| 2020 | 18 | 982 | 4,737 | $440,302 | $150,814 |
Total Patients
4,417
Total Services
21,866
Medicare Billing
$697,232
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 103 | 103 | $171,245 | $64,683 | 37.8% |
| 67900 | Repair of brow paralysis | Facility | 2023 | 76 | 76 | $108,827 | $21,863 | 20.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 33 | 4,905 | $61,518 | $20,285 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 130 | 130 | $42,145 | $15,625 | 37.1% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 34 | 88 | $27,797 | $9,996 | 36.0% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Facility | 2023 | 14 | 14 | $18,280 | $6,931 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 73 | $18,227 | $6,502 | 35.7% |
| 67911 | Correction of widely-opened upper eyelid | Facility | 2023 | 14 | 17 | $20,046 | $6,183 | 30.8% |
| 67882 | Creation of permanent eyelid margin scarring with relocation of eyelid tissue | Facility | 2023 | 19 | 19 | $19,105 | $5,863 | 30.7% |
| 92285 | Photography of content of eyes | Office | 2023 | 303 | 359 | $15,982 | $5,833 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 88 | $15,585 | $4,699 | 30.2% |
| 67840 | Removal of growth of eyelid | Facility | 2023 | 43 | 60 | $19,303 | $4,492 | 23.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 45 | 45 | $13,303 | $3,430 | 25.8% |
| 67916 | Repair of turning-outward eyelid defect | Facility | 2023 | 17 | 19 | $17,000 | $3,321 | 19.5% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 28 | 30 | $9,841 | $3,292 | 33.4% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 129 | 133 | $8,637 | $2,775 | 32.1% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 11 | 14 | $7,647 | $2,654 | 34.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $5,441 | $2,048 | 37.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 36 | $3,954 | $1,550 | 39.2% |
| 68815 | Probing of nasal tear duct with insertion of tube or stent | Facility | 2023 | 12 | 13 | $6,419 | $1,495 | 23.3% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 11 | 11 | $1,863 | $526.71 | 28.3% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2022 | 93 | 93 | $157,853 | $60,870 | 38.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 32 | 4,215 | $50,580 | $17,641 | 34.9% |
| 67900 | Repair of brow paralysis | Facility | 2022 | 49 | 49 | $68,666 | $13,439 | 19.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 119 | 119 | $35,224 | $12,781 | 36.3% |
About Dr. Bryant Carruth, MD
Dr. Bryant Carruth, MD is a Ophthalmology healthcare provider based in North Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1760645790.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryant Carruth, MD has received a total of $37,741 in payments from pharmaceutical and medical device companies, with $27.84 received in 2024. These payments were reported across 60 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($17,025).
As a Medicare-enrolled provider, Carruth has provided services to 4,417 Medicare beneficiaries, totaling 21,866 services with total Medicare billing of $697,232. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmic Plastic and Reconstructive Surgery
- Location North Syracuse, NY
- Active Since 07/09/2008
- Last Updated 03/19/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1760645790
Products in Payments
- TEPEZZA (Drug) $36,590
- Xeomin (Biological) $66.22
- TEPEZZA (Biological) $27.84
- ACTHAR (Biological) $23.18
- VUITY (Drug) $14.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.